These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22044537)

  • 1. A model for predicting size distributions delivered from pMDIs with suspended drug.
    Stein SW; Sheth P; Myrdal PB
    Int J Pharm; 2012 Jan; 422(1-2):101-15. PubMed ID: 22044537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling and Understanding Combination pMDI Formulations with Both Dissolved and Suspended Drugs.
    Stein SW; Sheth P; Younis US; Mogalian E; Myrdal PB
    Mol Pharm; 2015 Sep; 12(9):3455-67. PubMed ID: 26258647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing aerodynamic particle size distribution of suspension pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    AAPS PharmSciTech; 2015 Feb; 16(1):192-201. PubMed ID: 25273026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Medication Velocity and Size Distribution from Pressurized Metered-Dose Inhalers by Phase Doppler Anemometry.
    Alatrash A; Matida E
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):501-513. PubMed ID: 27504720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent?
    Ong HX; Traini D; Loo CY; Sarkissian L; Lauretani G; Scalia S; Young PM
    Eur J Pharm Biopharm; 2015 Jun; 93():320-7. PubMed ID: 25930239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers.
    Schroeter JD; Sheth P; Hickey AJ; Asgharian B; Price OT; Holt JT; Conti DS; Saluja B
    AAPS PharmSciTech; 2018 Jul; 19(5):2335-2345. PubMed ID: 29858973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of the OptiChamber Diamond valved holding chamber.
    Hatley RH; von Hollen D; Sandell D; Slator L
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S24-36. PubMed ID: 25054480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.
    Traini D; Young PM; Rogueda P; Price R
    Pharm Res; 2007 Jan; 24(1):125-35. PubMed ID: 17103336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonuniform Deposition of Pressurized Metered-Dose Aerosol in Spacer Devices.
    Ogrodnik N; Azzi V; Sprigge E; Fiset S; Matida E
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):490-500. PubMed ID: 27224033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is "Slow Inhalation" Always Suitable for Pressurized Metered Dose Inhaler?
    Hira D; Okuda T; Mizutani A; Tomida N; Mizuno M; Ueshima S; Kakumoto M; Okano T; Okamoto H
    AAPS PharmSciTech; 2020 Jan; 21(2):53. PubMed ID: 31907655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
    Adi H; Young PM; Traini D
    J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting physical stability in pressurized metered dose inhalers via dwell and instantaneous force colloidal probe microscopy.
    D'Sa D; Chan HK; Chrzanowski W
    Eur J Pharm Biopharm; 2014 Sep; 88(1):129-35. PubMed ID: 25058596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
    Murnane D; Martin GP; Marriott C
    Pharm Res; 2008 Oct; 25(10):2283-91. PubMed ID: 18509598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
    Pu Y; Kline LC; Berry J
    Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
    Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.